Clinical Trials Logo

Clinical Trial Summary

In our study we aimed to compare the lactation process by mothers who were undergoing elective Caesarian section under general anesthesia, spinal anesthesia, epidural anesthesia and normal vaginal birth.


Clinical Trial Description

Patients were randomly divided into 4 groups: group G (general anesthesia for Caesarean section, n=21), group S (spinal anesthesia for Caesarean section, n=21), group E (epidural anesthesia for Caesarean section, n=21), group V (normal vaginal birth without anesthesia, n=21). Blood sample of 3 mililiters was taken from all patients 2,5 hours before procedure and oxytocin and prolactin levels in this blood samples were determined. No patient received premedication. Group G (general anesthesia for Caesarean section) received preoxygenation with 100% oxygen for 3-5 minutes before intubation. In order to let fetus minimally affected by the anesthetic agents, induction was performed after the disinfection and covering up of surgery area. Induction was performed with propofol (2 mg/ kg) and rocuronium (0,6 mg/kg). After onset of neuromuscular block, patients were intubated with compression maneuver of cricoid cartilage. Controlled ventilation was provided with anesthesia machine Datex Ohmeda S/5 Avance with tidal volume of 8-10 ml/kg, respiration frequency of 10-12 min. Anesthesia was maintained with oxygen (50%) , air (50%), sevoflurane of 1 MAC. When necessary rocuronium 0,15 mg/kg was administered. After delivery of the newborn, fentanyl 1-1,5 mcg/ kg was administered.

Patients in group S (spinal anesthesia for Caesarean section) received 750-1000 mL of 0,9% NaCI solution (10-15 mL/kg) as infusion in 20-30 minutes. Under strict aseptic precautions a 25G Quincke spinal needle was introduced into L3-L4 or L4-L5 intervertebral space in midline approach in sitting posture, and, after confirming free flow of CSF, predetermined 10-11 mg of drug solution (hypertonic bupivacaine 0,5%) was injected. We let the operation begin when sensory and motor blockade were verified. Oxygen of 100% (3 L. min) was administered throughout the operation via nasal cannula.

Patients in group E (epidural anesthesia for Caesarean section) received 750-1000 mL of 0,9% NaCI solution (10-15 mL/kg) as infusion in 20-30 minutes. We conducted epidural anesthesia with 18-gauge Tuohy needle at L3-L4 or L4-L5 epidural space by midline approach at sitting position. 3 -5 minutes after injection of 3 ml lidocaine as test-dose, when the patient has no sign of subarachnoid injection like prickling in lower extremities or of intravascular injection like nausea, vomiting, tachicardia, tinnitus, a 20-gauge epidural catheter was inserted to cephalad. We injected 10 ml of 0.5% bupivacaine via epidural catheter. We let the operation begin when sensory and motor blockade were verified. Oxygen of 100% (3 L. min) was administered throughout the operation via nasal cannula.

Patients in all 3 groups were monitorised in the operation room with a monitor of Datex-Ohmeda and electrocardiogram (ECG), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP), heart rate (HR), peripheral oxygen saturation (SPO2) were recorded. Efedrin 5-10 mg and/or atropin 0,5 mg was administered when significant hypotension and bradicardia occurred. After delivery of the newborn 30 IU of oxytocin in a 1000cc solution of 0,9% NaCI was infused and if patient was not hypertensive, methylergonovine of 0,2 mg was administered intramuscular.

Patients in group V (spontaneous vaginal birth without anesthesia) were spectated by gynecologists in the Clinic of Gynecology and Obstetrics during the delivery. They received no anesthesia.

In all groups blood samples were taken at the 24th hour after delivery and oxytocin and prolactin levels were measured. Plasma of blood samples taken before and after delivery were stored at a temperature of -80°C. Prolactin levels were determined with chemiluminescense immunoassay technique Cobas e 601 (Roche® Diagnostics, Mannheim, Germany) using a commercial kit (Roche®). Oxytocin levels were determined with a commercial ELISA kit (Cusabio Biotech CO. Ltd). By all patients onset time of lactation was recorded. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02016937
Study type Observational [Patient Registry]
Source Duzce University
Contact
Status Completed
Phase N/A
Start date January 2011
Completion date February 2012

See also
  Status Clinical Trial Phase
Completed NCT02510170 - Fetal and Maternal Head Circumference During Pregnancy in Israeli Population N/A
Recruiting NCT05100550 - Family-based Health Education Program and Zinc Supplementation for Stunted Mother N/A
Completed NCT03413631 - A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women N/A
Recruiting NCT06271889 - The Effect of Electro-fetal monıtorısıon Sound on Anxiety, paın and Postpartum Bonding at the First Phase of Delivery N/A
Active, not recruiting NCT06160583 - General Anesthesia for Cesarean Section, Maternal and Perinatal Outcomes
Recruiting NCT06035315 - The 1000 First Day of Life : Effect of Multi Micronutrients Supplementation on Pregnancy Outcomes N/A
Completed NCT03883971 - Third Trimester 3D Printed Models Versus 3D Ultrasound Effects on Maternal-Fetal Attachment N/A
Recruiting NCT05293795 - 3D U/S Maternal Fetal Bonding in African American Women N/A
Completed NCT04337320 - Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study
Completed NCT05744531 - Internet Based Parenting Education and Information -Motivation-Behavioral Skills (IMB) Model N/A
Enrolling by invitation NCT05804838 - Investigation of the Effect of Mindfulness-Based Stress Reduction Program on in Pregnant Women N/A
Recruiting NCT04541121 - 3D Maternal Fetal Attachment and Smoking N/A
Completed NCT01931540 - Developmental ORIgins of Healthy and Unhealthy AgeiNg: the Role of Maternal Obesity N/A
Completed NCT00970151 - Determinants of Fetal Inflammatory Exposure at Term N/A
Completed NCT05429242 - The Relation Between Placental Volume at the 1st Trimester and Perinatal Prognosis
Not yet recruiting NCT05856396 - Maternal Determinants of Infant Immunity to Pertussis Phase 4
Not yet recruiting NCT05462431 - The Effect of Web-Based Deep Relaxation Exercises in Pregnant Women N/A
Recruiting NCT05910346 - The Effect of Training and Counseling Based on Mercer Maternal Role Theory on Maternal Attachment and Maternal Function N/A
Completed NCT03938129 - Improving Women's and Children's Health Via Biobanking and Electronic Registry
Completed NCT02674126 - The Efficacy of Maternal Sound for Pediatric Patients Undergoing Cardiac Surgery Phase 2